Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2010
03/04/2010US20100055714 IKB kinase, subunits thereof, and methods of using same
03/04/2010US20100055696 DRG11-Responsive (DRAGON) Gene Family
03/04/2010US20100055687 Mutations in the BCR-ABL tyrosine kinase associated with resistance to ST1-571
03/04/2010US20100055201 Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
03/04/2010US20100055197 Long-term enteral feed for maintenance
03/04/2010US20100055195 Biodegradable bmp nanofiber and uses thereof
03/04/2010US20100055184 Hydrogels for vocal cord and soft tissue augmentation and repair
03/04/2010US20100055183 Trimeprazine and ethopropazine derivatives for promoting bone growth
03/04/2010US20100055169 Cationic lipids and uses thereof
03/04/2010US20100055168 Cationic lipids and uses thereof
03/04/2010US20100055164 Synthetic lung surfactant and use thereof
03/04/2010US20100055158 Environmentally Activated Compositions, Articles and Methods
03/04/2010US20100055150 Method and composition for treatment of skeletal dysplasias
03/04/2010US20100055147 Angiotensin (1-7) eluting stent
03/04/2010US20100055146 Cyclic angiotensin analogs
03/04/2010US20100055130 Staphylococcus aureus proteins and nucleic acids
03/04/2010US20100055125 Peptide Library
03/04/2010US20100055124 BRACHYSPIRA PILOSICOLI 72kDa OUTER-MEMBRANE PROTEIN AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
03/04/2010US20100055123 Vaccine against burkholderia infections
03/04/2010US20100055122 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
03/04/2010US20100055118 Peptidic Growth Hormone Secretagogues Analog Compounds and Preparations Thereof
03/04/2010US20100055114 Use of integrin alpha 10 binding antibody to modulate extracellular matrix (cartilage) turnover
03/04/2010US20100055106 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof
03/04/2010US20100055105 Novel Isolated And Purified Strains Of Chikungunya Virus And Polynucleotides And Polypetide Sequences, Diagnostic And Immunogenical Uses Thereof
03/04/2010US20100055101 Cytokine receptor zcytor17 multimers
03/04/2010US20100055093 Pan-cell surface receptor-specific therapeutics
03/04/2010US20100055091 Novel GL-50 Molecules and Uses Therefor
03/04/2010US20100055089 Methods for Inhibition of Lymphangiogenesis and Tumor Metastasis
03/04/2010US20100055088 CXCR4 Antagonists for Wound Healing and Re-Epithelialization
03/04/2010US20100055087 Methods and compositions for delivering interleukin-1 receptor antagonist
03/04/2010US20100055086 Antimicrobial Flush Solutions
03/04/2010US20100055085 Hydrolases, nucleic acids encoding them and methods for making and using them
03/04/2010US20100055081 Long-lasting absorption of flavonoids
03/04/2010US20100055077 Methods for increasing and mobilizing hematopoietic stem cells
03/04/2010US20100055072 2-oxo-1,2-dihydro-quinoline modulators of immune function
03/04/2010US20100055071 Anti-Viral Compounds
03/04/2010US20100055070 Cytokine-based fusion proteins for treatment of immune disorders
03/04/2010US20100055069 Hpv-18-based papillomavirus vaccines
03/04/2010US20100055059 Association of compounds inhibiting melanogenesis and use thereof in cosmetics and dermatology
03/04/2010US20100055049 Insulin derivative formulations for pulmonary delivery
03/04/2010DE202008017680U1 Zubereitungen mit Hagebuttenextrakten Preparations with rosehip extracts
03/04/2010CA2736860A1 Methods of treatment using single doses of oritavancin
03/04/2010CA2735522A1 Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
03/04/2010CA2735439A1 Analysis of hcv genotypes
03/04/2010CA2735421A1 Delivery of a cd40 agonist to a tumor draining lymph node of a subject
03/04/2010CA2735263A1 Adiponectin for treating pulmonary disease
03/04/2010CA2735230A1 Hydrolases, nucleic acids encoding them and methods for making and using them
03/04/2010CA2735077A1 Antimicrobial agents
03/04/2010CA2730721A1 Biopolymer conjugates comprising an interleukin-11 analog
03/03/2010EP2159230A1 Anti-TNF antibodies, compositions, methods and uses
03/03/2010EP2159229A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same
03/03/2010EP2158923A1 Peg-urate oxidase conjugates and use thereof
03/03/2010EP2158920A1 Stabilizing alkylglycoside compositions and methods thereof
03/03/2010EP2158919A1 Method for reducing postprandial glucose levels with a composition of whey protein and fiber
03/03/2010EP2158918A1 Method for reducing postprandial glucose levels with a composition of whey protein
03/03/2010EP2158917A1 P.ariasi polypeptides, P.perniciosus polypeptides and methods of use
03/03/2010EP2158901A2 Alpha aztreonam lysinate
03/03/2010EP2158900A1 Polymeric delivery formulations of leuprolide with improved efficacy
03/03/2010EP2158898A1 Stabilizing alkylglycoside compositions and method thereof
03/03/2010EP2158319A1 Bone targeted alkaline phosphatase, kits and methods of use thereof
03/03/2010EP2158216A1 Splice-variants of g-protein coupled receptor ep3 and uses thereof
03/03/2010EP2158214A1 Glucagon analogues
03/03/2010EP2158213A1 Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity and decrease the in vivo dth-responses in rats
03/03/2010EP2158211A2 Mutated structural protein of a parvovirus
03/03/2010EP2157979A1 Calcium channel proteins and uses thereof
03/03/2010EP2157967A2 Suspension formulations of insulinotropic peptides and uses thereof
03/03/2010EP2157908A1 Method for measuring the response of a tissue to an electromagnetic field
03/03/2010EP1828225B1 Purified rhigf-i/rhigfbp-3 complexes and their method of manufacture
03/03/2010EP1756270B1 Diagnosis and treatment of myeloid and lymphoid cell cancers with chlorotoxin or a derivative
03/03/2010EP1743648B1 Method for treating inflammation
03/03/2010EP1730166B1 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections
03/03/2010EP1694848B1 Novel chimeric plasminogen activators and their pharmaceutical use
03/03/2010EP1613274B1 Human il-18 substitution mutants and their conjugates
03/03/2010EP1569683B1 Modified natriuretic compounds, conjugates, and uses thereof
03/03/2010EP1569656B1 Phosphoantigens for regulating an immune response
03/03/2010EP1519952B1 Use of aspartic proteases in cosmetics and therapeutics
03/03/2010EP1286682B1 Methods and compositions for inhibiting immunoglobulin-mediated-reperfusion injury
03/03/2010CN101663047A Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
03/03/2010CN101663046A modified fgf-21 polypeptides and their uses
03/03/2010CN101663045A A composition containing arazyme for the prevention and treatment of cancer
03/03/2010CN101663044A triazole macrocycle systems
03/03/2010CN101663043A Methods and compositions for fostering and preserving bone growth
03/03/2010CN101663042A Method for producing an antitumoral vaccine based on surface endothelial cell antigens
03/03/2010CN101659704A Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
03/03/2010CN101658666A Glutathione derivative and anti-tumor medical application thereof
03/03/2010CN100592919C Spray for treating chronic pharyngitis
03/02/2010USRE41157 Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
03/02/2010US7671258 Surfactant peptide nanostructures, and uses thereof
03/02/2010US7671252 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof
03/02/2010US7671185 Polynucleotide encoding a variant polypeptide of wild-type DsRed or DsRed.T4, a tetrameric variant that has reduced oligomerization relative wild-type DsRed and a fluorescence spectra similar to the fluorescence spectra of the wild-type DsRed
03/02/2010US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents
03/02/2010US7671177 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders
03/02/2010US7671176 host cells that contain an isolated nucleic acid molecule that encodes a polypeptide having mu3 opiate receptor activity; for identifying mu3 opiate receptor agonists and antagonists
03/02/2010US7671175 animal feed additive; detergent; defensins; exhibit reduced hemolytic activity, cytotoxicity and sensitivity towards cations, such as Ca2+, Mg2+, Na+.
03/02/2010US7671174 appetite stimulants, antiobesity drugs, prolactin production inhibitors; drug screening; G-protein coupled (GPR)
03/02/2010US7671091 Administering vasodilator in carrier or diluent
03/02/2010US7671082 4-Amino-2,2-dioxo-2 lambda 6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid diethyl ester; glutamate receptor agonist; antidepressant, anxiolytic agent psychological, and psychiatric disorders; acylation amino compounds with amino acyl, deprotection
03/02/2010US7671041 Glycosaminoglycans; food complements, medicaments; joint pain, obesity; bioavailability
03/02/2010US7671036 Positively-charged peptide nucleic acid analogs with improved properties
03/02/2010US7671035 Epidermal growth factor receptor antisense oligonucleotides
1 ... 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 ... 3163